These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34959645)

  • 61. Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens.
    Mishra B; Lakshmaiah Narayana J; Lushnikova T; Wang X; Wang G
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13517-13522. PubMed ID: 31209048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
    Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
    Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.
    Kiattiburut W; Zhi R; Lee SG; Foo AC; Hickling DR; Keillor JW; Goto NK; Li W; Conlan W; Angel JB; Wang G; Tanphaichitr N
    Hum Reprod; 2018 Dec; 33(12):2175-2183. PubMed ID: 30357408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application.
    Dostert M; Belanger CR; Hancock REW
    J Innate Immun; 2019; 11(3):193-204. PubMed ID: 30134244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LL-37 fragments have antimicrobial activity against Staphylococcus epidermidis biofilms and wound healing potential in HaCaT cell line.
    Saporito P; Vang Mouritzen M; Løbner-Olesen A; Jenssen H
    J Pept Sci; 2018 Jul; 24(7):e3080. PubMed ID: 29737589
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway.
    He M; Zhang H; Li Y; Wang G; Tang B; Zhao J; Huang Y; Zheng J
    Front Immunol; 2018; 9():722. PubMed ID: 29706959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
    Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
    Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The π Configuration of the WWW Motif of a Short Trp-Rich Peptide Is Critical for Targeting Bacterial Membranes, Disrupting Preformed Biofilms, and Killing Methicillin-Resistant Staphylococcus aureus.
    Zarena D; Mishra B; Lushnikova T; Wang F; Wang G
    Biochemistry; 2017 Aug; 56(31):4039-4043. PubMed ID: 28731688
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ratio of ellipticities between 192 and 208 nm (R
    Banerjee R; Sheet T
    Proteins; 2017 Nov; 85(11):1975-1982. PubMed ID: 28707342
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms.
    Mishra B; Wang G
    Pharmaceuticals (Basel); 2017 Jun; 10(3):. PubMed ID: 28672834
    [No Abstract]   [Full Text] [Related]  

  • 71. Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides.
    Mishra B; Golla RM; Lau K; Lushnikova T; Wang G
    ACS Med Chem Lett; 2016 Jan; 7(1):117-21. PubMed ID: 26819677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. APD3: the antimicrobial peptide database as a tool for research and education.
    Wang G; Li X; Wang Z
    Nucleic Acids Res; 2016 Jan; 44(D1):D1087-93. PubMed ID: 26602694
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.
    Xhindoli D; Pacor S; Benincasa M; Scocchi M; Gennaro R; Tossi A
    Biochim Biophys Acta; 2016 Mar; 1858(3):546-66. PubMed ID: 26556394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis.
    Tripathi S; Wang G; White M; Rynkiewicz M; Seaton B; Hartshorn K
    PLoS One; 2015; 10(8):e0133454. PubMed ID: 26308522
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds.
    Wang G; Hanke ML; Mishra B; Lushnikova T; Heim CE; Chittezham Thomas V; Bayles KW; Kielian T
    ACS Chem Biol; 2014 Sep; 9(9):1997-2002. PubMed ID: 25061850
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human antimicrobial peptides and proteins.
    Wang G
    Pharmaceuticals (Basel); 2014 May; 7(5):545-94. PubMed ID: 24828484
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.
    Wang G; Elliott M; Cogen AL; Ezell EL; Gallo RL; Hancock RE
    Biochemistry; 2012 Jan; 51(2):653-64. PubMed ID: 22185690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
    Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
    Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
    Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.